Candida albicans cell membrane and morphogenesis pathways

Candida albicans is a polymorphic opportunistic pathogen whose virulence is closely tied to its ability to transition between yeast and hyphal forms, a process essential for tissue invasion (Sudbery, 2011, Nature Reviews Microbiology). The cell membrane serves as a vital structural component and a platform for signaling, with ergosterol being the primary sterol required for membrane fluidity and the function of membrane-bound enzymes (Lohse et al., 2018, Nature Reviews Microbiology). Morphogenesis is regulated by complex signaling networks, including the Ras1-cAMP-PKA and MAPK cascades, which respond to environmental cues to trigger hyphal growth (Shapiro et al., 2011, Microbiology and Molecular Biology Reviews). Therapeutic strategies often target the membrane by inhibiting ergosterol biosynthesis via the enzyme lanosterol 14-alpha-demethylase or by causing direct membrane leakage through sterol binding (Odds et al., 2003, Journal of Antimicrobial Chemotherapy). Additionally, targeting morphogenesis pathways is an area of active research aimed at attenuating virulence and overcoming the challenges of drug resistance in systemic candidiasis (Nobile & Johnson, 2015, Genetics). This approach focuses on preventing the transition to the invasive hyphal form rather than killing the fungus outright, potentially reducing selective pressure for resistance.

Other names

Candida albicans morphogenesisC. albicans plasma membraneYeast-to-hypha transition pathwaysFungal morphogenesis signaling

Inhibition of lanosterol 14-alpha-demethylase (ERG11) to deplete ergosterol, direct binding to ergosterol to create membrane pores, or modulation of cAMP/PKA and MAPK signaling to inhibit hyphal formation.